BackRayzeBio Overview

RayzeBio Current Cash

Latest current cash for RYZB: $250M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$251.96M

Peer average

Loading

RayzeBio Current Cash History

Loading

RayzeBio vs. peers: Current Cash Comparison

Loading

RayzeBio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RayzeBio (RYZB) FAQ

As of the most recent data (September 2023), RYZB shows a current cash of $250M. Scroll down for historical charts and peer comparison views.

Tracking RYZB's current cash over time shows whether RayzeBio is scaling, shrinking, or reshaping that part of the business. The current reading is $250M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has RayzeBio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $250M) with ownership activity and broader fundamentals.